Interleukin-13 receptors on human prostate carcinoma cell lines represent a novel target for a chimeric protein composed of IL-13 and a mutated form of Pseudomonas exotoxin.
暂无分享,去创建一个
I. Pastan | G. Haas | R. Puri | W. Debinski | J. Pontes | I Pastan | A Maini | G Hillman | G P Haas | C Y Wang | E Montecillo | F Hamzavi | J E Pontes | P Leland | W Debinski | R K Puri | P. Leland | G. Hillman | E. Montecillo | A. Maini | F. Hamzavi | C. Wang
[1] E. Thiel,et al. Inhibition of proliferation and clonal growth of human breast cancer cells by interleukin 13. , 1996, Cancer research.
[2] R. Puri,et al. The IL-13 receptor structure differs on various cell types and may share more than one component with IL-4 receptor. , 1997, Journal of immunology.
[3] R. de Waal Malefyt,et al. Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[4] J. Banchereau,et al. Interleukin-13 inhibits the proliferation of normal and leukemic human B-cell precursors. , 1994, Blood.
[5] R. de Waal Malefyt,et al. IL-13 induces proliferation and differentiation of human B cells activated by the CD40 ligand. , 1993, International immunology.
[6] I. Pastan,et al. Receptor for interleukin 13 on AIDS-associated Kaposi's sarcoma cells serves as a new target for a potent Pseudomonas exotoxin-based chimeric toxin protein. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[7] R. Kurzrock,et al. Cytokines: Interleukins and Their Receptors , 2011, Cancer Treatment and Research.
[8] J. Johnson,et al. Growth stimulation of human head and neck squamous cell carcinoma cell lines by interleukin 4. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.
[9] P. Casellas,et al. lnterleukin-13 is a new human lymphokine regulating inflammatory and immune responses , 1993, Nature.
[10] C. Figdor,et al. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-gamma or IL-10. , 1993, Journal of immunology.
[11] C. Figdor,et al. Effects of interleukin 4 on monocyte functions: comparison to interleukin 13. , 1993, Research in immunology.
[12] J. D. de Vries,et al. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. , 1994, Immunology today.
[13] R. Puri,et al. Receptor for Interleukin 13 , 1995, The Journal of Biological Chemistry.
[14] R. de Waal Malefyt,et al. An interleukin 4 (IL-4) mutant protein inhibits both IL-4 or IL-13- induced human immunoglobulin G4 (IgG4) and IgE synthesis and B cell proliferation: support for a common component shared by IL-4 and IL-13 receptors , 1993, The Journal of experimental medicine.
[15] R. Puri. Structure and function of interleukin-4 and its receptor. , 1995, Cancer treatment and research.
[16] A. Minty,et al. Interleukin 13 is a B cell stimulating factor , 1994, The Journal of experimental medicine.
[17] I. Pastan,et al. Recombinant toxins as novel therapeutic agents. , 1992, Annual review of biochemistry.
[18] R. Puri,et al. Interleukin 13 inhibits growth of human renal cell carcinoma cells independently of the p140 interleukin 4 receptor chain. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.
[19] R. Puri,et al. Interleukin-4 and cancer therapy. , 1993, Cancer investigation.
[20] R. Puri,et al. Receptor for Interleukin (IL) 13 Does Not Interact with IL4 but Receptor for IL4 Interacts with IL13 on Human Glioma Cells* , 1996, The Journal of Biological Chemistry.
[21] D Rodbard,et al. Ligand: a versatile computerized approach for characterization of ligand-binding systems. , 1980, Analytical biochemistry.
[22] J. D. de Vries,et al. IL-13 induces proliferation, Ig isotype switching, and Ig synthesis by immature human fetal B cells. , 1994, Journal of immunology.
[23] I. Pastan,et al. A Novel Chimeric Protein Composed of Interleukin 13 and Pseudomonas Exotoxin Is Highly Cytotoxic to Human Carcinoma Cells Expressing Receptors for Interleukin 13 and Interleukin 4 (*) , 1995, The Journal of Biological Chemistry.
[24] I. Pastan,et al. Human glioma cells overexpress receptors for interleukin 13 and are extremely sensitive to a novel chimeric protein composed of interleukin 13 and pseudomonas exotoxin. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.
[25] I. Pastan,et al. Targeting of interleukin-13 receptor on human renal cell carcinoma cells by a recombinant chimeric protein composed of interleukin-13 and a truncated form of Pseudomonas exotoxin A (PE38QQR). , 1996, Blood.